Centene Completes Carolina Complete Health and WellCare of North Carolina Merger Under Unified Brand

CNC
April 02, 2026

Centene Corporation announced that its subsidiaries Carolina Complete Health and WellCare of North Carolina have merged under the Carolina Complete Health brand, following regulatory approval received on April 2, 2026. The combined entity will serve more than 980,000 members across Medicaid, Medicare, and Marketplace plans, expanding Centene’s footprint in the southeastern United States.

The merger consolidates the two companies’ provider networks, administrative infrastructure, and behavioral health services, creating a larger, more efficient managed‑care organization. By unifying under a single brand, Centene aims to streamline operations, reduce duplication of effort, and enhance its competitive position in North Carolina’s Medicaid and Medicare Advantage markets.

Centene’s broader strategy is to leverage local provider‑led models while centralizing administrative functions for greater scale. Carolina Complete Health was established as a provider‑led health plan, with local physicians determining clinical policy, and that model will be maintained in the combined entity. The merger is expected to strengthen Centene’s scale advantage, improve cost efficiencies, and broaden its service offerings in a key growth region.

Current members of both Carolina Complete Health and WellCare of North Carolina will not experience changes to their benefits or providers. The combined organization will continue to deliver Centene’s core government‑program expertise while offering enhanced value‑added services, such as expanded behavioral health and care coordination.

The transaction aligns with Centene’s recent financial performance, which has shown steady revenue growth: Q4 2024 premium and service revenues rose 3% to $36.3 billion, and full‑year 2024 revenues increased 4% to $145.5 billion. In Q1 2025, revenues grew 17% year‑over‑year to $42.5 billion, and Q4 2025 revenues reached $49.7 billion, a 21.9% increase. The merger is positioned to support Centene’s guidance for 2026, which expects adjusted diluted EPS greater than $3.00.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.